ARCHIVES

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

This article is from The Cancer Letter archive.

Vol. 34 No. 08 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Encourages IP Chemo For Stage III Ovarian Cancer

January 27, 2006

NCI Toughens Criteria for MERIT Awards

February 23, 1996

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

In Brief: French 10 Years Behind In Treatment Techniques, Rauscher Tells Premier; European Interest Grows

September 26, 1975

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993

Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25

February 22, 1980